Dr. Bhindi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St SW
Rochester, MN 55905Phone+1 403-943-8964Fax+1 403-943-8919- Is this information wrong?
Summary
- I am a Royal College-certified urologic oncologist working at the Southern Alberta Institute of Urology in Calgary, Alberta, Canada. I focus in all areas of urologic oncology. I am interested in health services and outcomes research in prostate and kidney cancer.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Minimally Invasive Urologic Surgery, 2016 - 2018
- University of TorontoFRCSC, Residency in Urology, 2009 - 2016
- University of TorontoMSc, Clinical Epidemiology and Health Care Research, 2012 - 2014
- McGill University Faculty of MedicineClass of 2009
Certifications & Licensure
- MN State Medical License 2016 - 2019
- WI State Medical License 2016 - 2017
Awards, Honors, & Recognition
- Claire Bombardier Award Institute for Health Policy Management and Evaluation, University of Toronto, 2014
- Best Poster Award Canadian Urological Association Annual Meeting, 2014
- Best poster award University of Toronto Institute of Health Policy Management and Evaluation Research Day, 2013
Publications & Presentations
PubMed
- 9 citationsSplit Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy.Nityam Rathi, Yosuke Yasuda, Diego Aguilar Palacios, Worapat Attawettayanon, Jianbo Li, Bimal Bhindi, R Houston Thompson, Michael A Liss, Ithaar H Derweesh, Christophe...> ;European Urology Open Science. 2022 Jun 1
- 2 citationsOutcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma.Jack R Andrews, Christine M Lohse, Stephen A Boorjian, Bradley C Leibovich, Houston Thompson, Brian A Costello, Bimal Bhindi> ;Urologic Oncology. 2022 Apr 1
- 3 citationsOutcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian Centers.Alice Dragomir, Sara Nazha, Simon Tanguay, Rodney H. Breau, Bimal Bhindi, Ricardo A. Rendon, Anil Kapoor, Sebastien J. Hotte, Naveen S. Basappa, Adrian Fairey, Alan I....> ;European Urology Focus. 2021 Nov 1
- Join now to see all
Journal Articles
- External evaluation of a novel prostate cancer risk calculator (ProstateCheck) based on data of the Swiss arm of the ERSPCPoyet C, Wettstein MS, Lundon DJ, Bhindi B, Kulkarni GS, Saba K, Sulser T, Vickers AJ, Hermanns T, J Urol, 1/1/2016
- Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical ProstatectomyBhindi B, Xie WY, Kulkarni GS, Hamilton RJ, Nesbitt M, Finelli A, Zlotta AR, Evans A, van der Kwast TH, Alibhai SM, Trachtenberg J, Fleshner NE, Urology, 1/1/2016
- The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisNayan M, Bhindi B, Yu JL, Mamdani M, Fleshner NE, Hermanns T, Chung P, Milosevic M, Bristow R, Warde P, Hamilton RJ, Finelli A, Jewett MAS, Zlotta AR, Sridhar SS, Kulk..., Can Urol Assoc J, 1/1/2016
- Join now to see all
Abstracts/Posters
- Is prostate cancer a marker for metabolic syndrome or good health? Analysis of a propensity-score matched population-based cohort.Bhindi B, Fleshner NE, Kulkarni GS, Sutradhar R, Lipscombe LL, Jembere N, Saskin R, Alibhai SMH, Canadian Urological Association 2013 Annual Meeting, Niagara Falls, ON, 1/30/2015
- Determining the best complete blood count-based biomarker for oncologic outcomes following radical cystectomy for urothelial carcinoma of the bladder. Moderated poster...Bhindi B, Hermanns T, Wei Y, Yu J, Templeton A, Noon AP, Bhatt JR, Richard PO, Almatar A, Jewett MAS, Hamilton RJ, Finelli A, Fleshner NE, Zlotta AR, and Kulkarni GS, Canadian Urological Association 2013 Annual Meeting, Niagara Falls, ON, 1/30/2015
- Prognostic utility of the neutrophil-tolymphocyte ratio in a large cohort of 2,407 men undergoing radical prostatectomy for clinically localized prostate cancer.Bhindi B, Hermanns T, Wei Y, Templeton A, Richard PO, Bhatt JR, Noon AP, Jewett MAS, Hamilton RJ, Trachtenberg, J, Finelli A, Fleshner NE, Zlotta AR, Kulkarni GS, Canadian Urological Association Annual Meeting, Niagara Falls, ON, 1/30/2015
- Join now to see all
Authored Content
- The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and TreatmentJuly 2018
Press Mentions
- Don't Avoid Vasectomy for Fear of Prostate Cancer: StudyJuly 18th, 2017
- RRP plus Castration Linked to Improved SurvivalMay 15th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: